Quantify

NovoCure Limited vs Pfizer, Inc. — Stock Comparison

NovoCure Limited (NVCR) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.

vs
Q·Score Winner
Pfizer, Inc.
PFE6.1/10vs 5.6/10

Pfizer, Inc. narrowly edges NovoCure Limited on Q·Score (6.1 vs 5.6 out of 10), led by Quality (5.7 vs 1.1) and Valuation (7.2 vs 6.8). NovoCure Limited scores higher on Growth, reflecting stronger revenue and earnings momentum. Analyst consensus targets imply greater upside for NVCR (+82.9%) than for PFE (+14.9%).

Price Performance

Normalised to 100 at period start — shows relative performance.

Loading…
● NVCR● PFE

Q·Score Breakdown

5.6
Neutral
Overall
6.1
Neutral
1.1
Quality
5.7
7.4
Health
7
7.7
Growth
5.1
6.8
Valuation
7.2
6
Sentiment
5.2
NVCR

Revenue expanding at 16% year-over-year.

⚠ currently unprofitable (-21% margin).

PFE

Forward P/E of 8.8× is low relative to sector peers.

⚠ earnings contracting 10% year-over-year.

Analyst Consensus

Bullish
+82.9%
Target $27.14
7 analysts
Neutral
+14.9%
Target $28.75
26 analysts

Fundamentals

NVCR
PFE
—
Trailing P/E
19.1×
-16.2×
Forward P/E
8.8×
-21.25%
Profit Margin
11.83%
76.37%
Gross Margin
74.80%
-43.22%
ROE
8.31%
15.60%
Revenue Growth
5.40%
—
Earnings Growth
-10.10%
0.94
Beta
0.31
—
Dividend Yield
6.88%
$1.7B
Market Cap
—
52-Week Range
NVCR
$1043% of range$21
PFE
$2330% of range$29

Frequently Asked Questions

NVCR vs PFE: which stock scores better overall?

Based on Q·Score, Pfizer, Inc. (PFE) scores 6.1/10 versus NovoCure Limited (NVCR) at 5.6/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.

Which has better revenue growth: NVCR or PFE?

NovoCure Limited (NVCR) scores higher on Growth (7.7/10 vs 5.1/10). NovoCure Limited reports revenue growth (15.6% YoY) while Pfizer, Inc. reports (5.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Is NVCR or PFE more attractively valued?

Pfizer, Inc. (PFE) scores higher on Valuation (7.2/10 vs 6.8/10). Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

What do analysts say about NVCR vs PFE?

There are 7 analysts covering NVCR with a consensus price target of $27.14, and 26 analysts covering PFE with a consensus target of $28.75. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Which is more profitable: NVCR or PFE?

Pfizer, Inc. (PFE) scores higher on Quality (5.7/10 vs 1.1/10). Net profit margin: NVCR at -21.2%, PFE at 11.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Which has stronger financial health: NVCR or PFE?

NovoCure Limited (NVCR) scores higher on Financial Health (7.4/10 vs 7/10). Market beta: NVCR at 0.94, PFE at 0.31. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

What are the market caps of NVCR and PFE?

NovoCure Limited (NVCR) has a market capitalisation of $1.7B, while Pfizer, Inc. (PFE) has a market cap of —. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Do NVCR or PFE pay dividends?

NVCR does not currently pay a dividend, while PFE pays a dividend yield of 6.88%. Dividend yields fluctuate with share price and company payout decisions.

Related Comparisons

JNJ vs PFEMRNA vs PFELLY vs PFE

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →

Data provided by Yahoo Finance ·  Updated on each page load ·  For informational purposes only · Not financial advice · Quantify.biz © 2026